Skip to main content

Physician Resources

Recently Added |view more

Integration, Location, Innovation: The Fox Chase-Temple Urologic Institute Leads the Way in Care News

Integration, Location, Innovation: The Fox Chase-Temple Urologic Institute Leads the Way in Care

At Temple Health, we’re no stranger to firsts—whether that means performing a pioneering surgery, opening a new type of facility, or offering a groundbreaking treatment. That’s why it’s no surprise that we’re also leading the way in Urology ...

Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses News

Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses

In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers from Fox Chase Cancer Center showed that using numerical cutoffs as opposed to radiologist-read CT scans to determine whether a mass ...

Fox Chase Researchers Examine Effects of Radiation Therapy Timing on Lifespan of Artificial Urinary Sphincters News

Fox Chase Researchers Examine Effects of Radiation Therapy Timing on Lifespan of Artificial Urinary Sphincters

In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers at Fox Chase Cancer Center showed that in men who have undergone surgery for prostate cancer, the function of artificial urinary sphincters ...

Putting the Nurse Back into Nurse Navigation News

Putting the Nurse Back into Nurse Navigation

More than 15 years ago, Fox Chase Cancer Center launched a Nurse Navigation system to expedite the journey through complex cancer care with experienced oncologic nurses as a patient’s first 'point-of-contact' via phone.

HER2-Targeted Agents: Not Just for Breast Cancer News

HER2-Targeted Agents: Not Just for Breast Cancer

With 20% of breast cancers driven by alterations to the HER2 gene, inhibiting the expression of this gene has been an objective of researchers and clinicians for decades, and a number of inhibitory therapies have been developed.

Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center News

Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center

Over the past year, the Fox Chase Cancer Center Radiation Oncology team led by Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase and the Lewis Katz School of Medicine at Temple University, has boldly ...

Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community News

Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community

Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be ...

Fox Chase Fellows – Winter 2024 News

Fox Chase Fellows – Winter 2024

People say you never really leave Fox Chase. Just ask Matt Zibelman, MD, who was a Fox Chase hematology/oncology fellow and now is the GU Service Line Director of Clinical and Translational Research—or his colleague Mark Hallman, MD, PhD, ...

Many Legacies to Carry On News

Many Legacies to Carry On

In May 2023, Michael O. Meyers, MD, a surgical oncologist at UNC, was named the James F. and Alice B. Newsome Distinguished Professor.